Sienna raises $65M in IPO

On July 26, dermatology company Sienna Biopharmaceuticals Inc. (NASDAQ:SNNA) raised $65 million through the sale of 4.3 million shares at $15 in an IPO on NASDAQ underwritten by JPMorgan, Cowen and B...